| HIV-1 uncoats in the nucleus near sites of integration RC Burdick, C Li, MH Munshi, JMO Rawson, K Nagashima, WS Hu, ... Proceedings of the National Academy of Sciences 117 (10), 5486-5493, 2020 | 277 | 2020 |
| Mycobacterium tuberculosis WhiB4 regulates oxidative stress response to modulate survival and dissemination in vivo M Chawla, P Parikh, A Saxena, MH Munshi, M Mehta, D Mai, ... Molecular microbiology 85 (6), 1148-1165, 2012 | 108 | 2012 |
| Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis R Mishra, S Kohli, N Malhotra, P Bandyopadhyay, M Mehta, MH Munshi, ... Science translational medicine 11 (518), eaaw6635, 2019 | 91 | 2019 |
| Measuring glutathione redox potential of HIV-1-infected macrophages A Bhaskar, MH Munshi, SZ Khan, S Fatima, R Arya, S Jameel, A Singh Journal of Biological Chemistry 290 (2), 1020-1038, 2015 | 62 | 2015 |
| Glycolysis downregulation is a hallmark of HIV‐1 latency and sensitizes infected cells to oxidative stress IL Shytaj, FA Procopio, M Tarek, I Carlon‐Andres, HY Tang, AR Goldman, ... EMBO molecular medicine 13 (8), e13901, 2021 | 39 | 2021 |
| Identifying and tackling emergent vulnerability in drug-resistant mycobacteria J Padiadpu, P Baloni, K Anand, MH Munshi, C Thakur, A Mohan, A Singh, ... ACS infectious diseases 2 (9), 592-607, 2016 | 32 | 2016 |
| Antioxidant nanozyme counteracts HIV‐1 by modulating intracellular redox potential S Singh, S Ghosh, VK Pal, MH Munshi, P Shekar, DT Narasimha Murthy, ... EMBO Molecular Medicine 13 (5), e13314, 2021 | 23 | 2021 |
| Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis. Sci Transl Med 11: eaaw6635 R Mishra, S Kohli, N Malhotra, P Bandyopadhyay, M Mehta, M Munshi, ... | 7 | 2019 |
| Publications Reported for this Reporting Period M Complete Chawla, P Parikh, A Saxena, M Munshi, M Mehta | | |
